Live
- Train crew suspended for violating speed limit
- Scrap NITI Aayog, bring back Planning Commission: Mamata
- Know your MLA: Satya Prabha continues husband’s legacy with resounding victory
- Dharani Revamp on Cards: CM calls for in-depth study to resolve Dharani lapses
- Huge scam in government ads
- NITI Aayog to focus on ‘Viksit Bharat @2047’
- PM playing petty politics: Oppn
- Jagan government destroyed AP economy says Chandrababu Naidu
- On Kargil Vijay Diwas, Modi hails Agnipath, targets Opposition
- War Of Words Over Kaleshwaram: Uttam accuses KTR of spreading lies
TS looks to focus on biotech, life sciences
Telangana Industries Minister Jupally Krishna Rao on Friday said the government would continue to recognise biotech and life sciences as a growth segment and was committed to promoting research, manufacturing and trade in this space.
Hyderabad: Telangana Industries Minister Jupally Krishna Rao on Friday said the government would continue to recognise biotech and life sciences as a growth segment and was committed to promoting research, manufacturing and trade in this space. “To tap this potential, we have recently announced a first-of-its-kind world-class Pharmacity, which will spread over 12,000 acres of land in Mucherla.
We will also improve educational infrastructure and as part of the Pharmacity, we plan to also have a Pharma University,” the Minister said while interacting with biotech industry leaders on the 13th edition of BioAsia conclave which will be held in the city from February 8.
Stating that Telangana would transform Hyderabad as the biotech and life sciences capital of the world, the Minister said several skill development initiatives were also in the pipeline.
Speaking on the occasion, Industries Secretary Avind Kumar said: “BioAsia has been a landmark event not only for the biotech and life sciences industry but also for Telangana. This year’s theme- ‘Connecting the Dots’ is very appropriate and aims to bridge the need gaps between all stakeholders of the industry”.
Telangana has taken many initiatives to address the issues and challenges being faced by the industry and we will continue to do so, he added. The meeting, organised as a precursor to BioAsia 2016 in association with Pharmexcil, had brought together captains of leading pharma and biotech industries, in addition to representatives from institutes.
